These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8119711)

  • 1. Neuroendocrine differentiation in prostatic adenocarcinoma does not represent true Paneth cell differentiation.
    di Sant'Agnese PA
    Hum Pathol; 1994 Feb; 25(2):115-6. PubMed ID: 8119711
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostatic adenocarcinoma with marked neuroendocrine differentiation.
    Islam AM; Kato H; Hayama M; Kobayashi S; Ota H; Nishizawa O
    Int J Urol; 2001 Jul; 8(7):412-5. PubMed ID: 11442667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases.
    Adlakha H; Bostwick DG
    Hum Pathol; 1994 Feb; 25(2):135-9. PubMed ID: 7509774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.
    di Sant'Agnese PA
    Urology; 1998 May; 51(5A Suppl):121-4. PubMed ID: 9610566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
    Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
    Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implication of neuroendocrine differentiation in prostatic adenocarcinomas.
    Constantinides C; Pavlaki K; Zizi D; Gavriel J; Mitropoulos D; Garifalos J; Dimopoulos C
    Urol Int; 1995; 55(3):134-6. PubMed ID: 8540155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of poorly differentiated adenocarcinoma of prostate with neuroendocrine differentiation].
    Miyoshi Y; Inoue Y; Matsuzaki J; Fukuda M; Satomi Y; Akahane H; Saito S
    Hinyokika Kiyo; 1998 Feb; 44(2):113-6. PubMed ID: 9546133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine differentiation in metastatic prostatic adenocarcinoma.
    Aprikian AG; Cordon-Cardo C; Fair WR; Zhang ZF; Bazinet M; Hamdy SM; Reuter VE
    J Urol; 1994 Apr; 151(4):914-9. PubMed ID: 8126824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostatic neuroendocrine cells].
    Herrero M; Rodríguez A; Cejas H
    Rev Fac Cien Med Univ Nac Cordoba; 2002; 59(1):91-6. PubMed ID: 12934249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroendocrine cancers of the prostate].
    Lépinard V; Dauge-Geffroy MC; Delmas V; Bertrand G; Fondimare A; Fetissof F
    Prog Urol; 1993 Feb; 3(1):86-94. PubMed ID: 8485600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasized 18F-DCFPyL-Negative Prostatic Adenocarcinoma Without Neuroendocrine Differentiation.
    Broos WAM; Kocken M; van der Zant FM; Knol RJJ; Wondergem M
    Clin Nucl Med; 2018 Feb; 43(2):120-122. PubMed ID: 29261618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.
    Bonkhoff H; Stein U; Remberger K
    Hum Pathol; 1995 Feb; 26(2):167-70. PubMed ID: 7532147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of prostatic adenocarcinoma with Paneth cell-like appearance.
    Nakamura Y; Fujishima F; Watanabe M; Taniuchi S; Ishida K; Ishidoya S; Arai Y; Sasano H
    Pol J Pathol; 2011; 62(1):60-4. PubMed ID: 21574107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin ligase Siah2 is revealed as an accomplice of the androgen receptor in castration resistant prostate cancer.
    Freeman MR
    Asian J Androl; 2013 Jul; 15(4):447-8. PubMed ID: 23708461
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroendocrine differentiation and prostatic carcinoma. The concept 'comes of age'.
    di Sant'Agnese PA
    Arch Pathol Lab Med; 1988 Nov; 112(11):1097-9. PubMed ID: 3178423
    [No Abstract]   [Full Text] [Related]  

  • 17. Divergent neuroendocrine differentiation in prostatic carcinoma.
    di Sant' Agnese PA
    Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
    Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
    Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochemical markers and DNA content of neuroendocrine cells in carcinoma of the prostate gland during tumour progression.
    Falkmer S; Askensten U; Grimelius L; Abrahamsson PA
    Acta Histochem Suppl; 1990; 38():127-32. PubMed ID: 2080236
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuro-endocrine cells--a new prognostic parameter in prostate cancer.
    Cohen RJ; Glezerson G; Haffejee Z
    Br J Urol; 1991 Sep; 68(3):258-62. PubMed ID: 1913066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.